Assignee
GILEAD CALISTOGA LLC
US·14 granted patents·10 pending applications·97 citations·filing 2012–2020
Top patents by PatentIndex Score
24 records- 0194US8865730B2Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2013·Granted Oct 21, 2014·25 cites·12 claims
- 0291US10059677B2Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereofGILEAD CALISTOGA LLC·Filed 2016·Granted Aug 28, 2018·8 cites·14 claims
- 0390US10047060B2Process methods for phosphatidylinositol 3-kinase inhibitorsGILEAD CALISTOGA LLC·Filed 2017·Granted Aug 14, 2018·7 cites·2 claims
- 0489US9567337B2Process methods for phosphatidylinositol 3-kinase inhibitorsGILEAD CALISTOGA LLC·Filed 2014·Granted Feb 14, 2017·10 cites·44 claims
- 0588US10414737B2Process methods for phosphatidylinositol 3-kinase inhibitorsGILEAD CALISTOGA LLC·Filed 2018·Granted Sep 17, 2019·5 cites·24 claims
- 0688US9708327B2Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2014·Granted Jul 18, 2017·12 cites·47 claims
- 0788US9469643B2Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2014·Granted Oct 18, 2016·9 cites·6 claims
- 0888US9029384B2Phosphatidylinositol 3-kinase inhibitorsGILEAD CALISTOGA LLC·Filed 2013·Granted May 12, 2015·10 cites·16 claims
- 0984US10730879B2Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2016·Granted Aug 4, 2020·2 cites·4 claims
- 1081US10442805B2Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2017·Granted Oct 15, 2019·3 cites·1 claims
- 1181US9238070B2Therapies for hematologic malignanciesGILEAD CALISTOGA LLC·Filed 2013·Granted Jan 19, 2016·3 cites·10 claims
- 1277US10954199B2Process methods for phosphatidylinositol 3-kinase inhibitorsGILEAD CALISTOGA LLC·Filed 2019·Granted Mar 23, 2021·0 cites·20 claims
- 1377US9018221B2Phosphatidylinositol 3-kinase inhibitorsGILEAD CALISTOGA LLC·Filed 2013·Granted Apr 28, 2015·3 cites·13 claims
- 1468US2020368243A1Therapies for hematologic malignanciesGILEAD CALISTOGA LLC·Filed 2020·Application pending·0 cites
- 1563US2014323439A1Therapies for hematologic malignanciesGILEAD CALISTOGA LLC·Filed 2014·Application pending·0 cites
- 1661US2019083498A1Therapies for hematologic malignanciesGILEAD CALISTOGA LLC·Filed 2018·Application pending·0 cites
- 1759US10154998B2Therapies for hematologic malignanciesGILEAD CALISTOGA LLC·Filed 2016·Granted Dec 18, 2018·0 cites·16 claims
- 1848US2013143902A1Compositions and methods of treating a proliferative disease with a quinazolinone derivativeGILEAD CALISTOGA LLC·Filed 2012·Application pending·0 cites
- 1948US2013344138A1Methods of treatment for solid tumorsGILEAD CALISTOGA LLC·Filed 2013·Application pending·0 cites
- 2048US2014051696A1Therapies for treating cancerGILEAD CALISTOGA LLC·Filed 2013·Application pending·0 cites
- 2146US2017119771A1Combination therapies for hematologic malignanciesGILEAD CALISTOGA LLC·Filed 2016·Application pending·0 cites
- 2242US2015196564A1Combination therapies for hematologic malignanciesGILEAD CALISTOGA LLC·Filed 2015·Application pending·0 cites
- 2341US2016016915A1Phosphatidylinositol 3-kinase inhibitorsGILEAD CALISTOGA LLC·Filed 2015·Application pending·0 cites
- 2441US2014235643A1Novel quinoxaline inhibitors of pi3kGILEAD CALISTOGA LLC·Filed 2012·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →